Disseminated on behalf of Bionano Genomics Inc.

“The Buzz” Show: Bionano Genomics (NASDAQ: BNGO) Skyrockets Following its Study on Autism Risk Genes



FinancialBuzz.com’s latest


The Buzz


Show: Featuring Our Corporate News Recap on “


Bionano Genomics


Skyrockets Following its


Study on Autism Risk Genes







Bionano Genomics (NASDAQ: BNGO)



surged over 69% in premarket trading after the company published a study on Autism Risk Genes via its CLIA certified diagnostic services subsidiary, Lineagen.


The study relied on the analysis of Professor Temple Grandin’s genome in one of the most comprehensive evaluations of a single genome of a high functioning individual with Autism Spectrum Disorder.


Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.




For more information, please visit:



Bionano Genomics, Inc.





About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

For further details see:


“The Buzz” Show: Bionano Genomics (NASDAQ: BNGO) Skyrockets Following its Study on Autism Risk Genes